SAMRATPH Stock View

Samrat Pharmachem Ltd
stock-view-header

icon -1.60 | -0.45
Market Cap ₹( Cr.)
1,100.86
Proj. P/E (x)
Proj. P/BV (x)
Proj. ROE (%)
Proj EV / EBITDA (x)
--
Proj. Revenue ( Cr.)

Stock View

Last Updated On.
03-Dec-2023
 

The average score for Samrat Pharmachem Ltd stands at 3 against 6, three months back.

Samrat Pharmachem Limited is an India-based company, which is engaged in the manufacturing and selling of pharmaceutical chemicals. The Company is a supplier of iodine derivatives to the Indian and foreign market. The Company’s products include 3-5-Di Iodosalicylic Acid, Ammonium Iodide, Calcium Iodide, Clioquinol, Copper Iodide, Ethyl Iodide, Ethylenediamine Dihydroiodide, Hydroiodic Acid 57%, Iodic Acid, Iodine, Iodine Monochloride, Iodoquinol, Lithium Iodide, Methyl Iodide, N-Iodo Succcinimide, Periodic Acid, Potassium Iodate, Potassium Iodide, Potassium Metaper Iodate, Povidone Iodine, Selenium Dioxide, Sodium Iodate, Sodium Iodide, Sodium Metaper Iodate, Sodium Selenite, Tetra Butyl Ammonium Iodide, and Tri Methyl Sulphoxonium Iodide. It serves various industries, such as agrochemical, animal feed, chemicals, food, pharmaceutical, printing, and textile. The Company exports its products to various countries, including United States, Europe, Africa, Asia, and Middle East.

Disclaimer : All estimates (1 year forward) are based on Consensus View provided by Refinitiv.


Technical Data

50 DMA(₹)
380.05
100 DMA(₹)
396.28
200 DMA(₹)
438.32
52 Weeks Range
332.00     894.00

Invest wise with Expert advice

mobile icon
  • Open Demat with exclusive Advice & Services
  • Get a dedicated Relationship Manager to help you grow your wealth
  • Exclusive advisory on 20+ trading & wealth based investment options
  • One tap Investments, Automated trading & much more
  • Minimum 1 lakh margin required